Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
Ketevan Pachkoria(Hospital Clínico Universitario Virgen de la Victoria), Raúl J. Andrade(Hospital Clínico Universitario Virgen de la Victoria), Manuel Romero‐Gómez(Instituto de Biomedicina de Sevilla), M. Carmen Fernández‐Santaella(Complejo Hospitalario Torrecárdenas), Ana Malcon de Dios(Hospital Universitario Virgen Macarena), Susana López-Ortega(Hospital Clínico Universitario Virgen de la Victoria), M. Isabel Lucena(Hospital Clínico Universitario Virgen de la Victoria), Esperanza Crespo(Universidad de Granada), José Antonio Durán(Hospital Universitario Virgen Macarena), Y. Borraz(Universidad de La Laguna), J.M. Navarro(Hospital Costa del Sol), Francisco Ruiz‐Cabello(Universidad de Granada)
Cited by 72
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k